CALCIUM ACETATE
| Brand name | PHOSLYRA |
|---|---|
| Active ingredient | CALCIUM ACETATE |
| Strength | 667MG/5ML |
| Dosage form | SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | April 2011 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8591938 | February 2030 | product |
| 8592480 | July 2027 | use U-1469 |
| 9089528 | July 2027 | use U-1469 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.